Homeo AI vs OpenEvidence: Free U.S. Evidence or Case Copilot?

Quick answer

Choose OpenEvidence when a verified United States healthcare professional wants a medical information platform for asking conventional clinical questions and reviewing linked evidence. Choose Homeo AI when a qualified homoeopathic practitioner needs to preserve a consultation narrative, review proposed symptoms and rubrics, inspect source passages, document a differential, and carry that reasoning into follow-ups.

OpenEvidence is an evidence-retrieval and clinical-information product. Homeo AI is a homoeopathic case-review copilot. Both can present confident prose and sources, but they solve different jobs. A source-backed answer to a conventional medical question is not a repertorisation, and a reviewable homoeopathic differential is not a replacement for current conventional guidance.

The price query also has an eligibility boundary. OpenEvidence's official public page advertises free access for verified United States healthcare professionals. A practitioner in India or another country should not assume that the same access, verification, product surface, or terms apply. Homeo AI should be evaluated under its own current account and trial terms.

What is current on 29 July 2026

OpenEvidence's official site describes the service as a medical information platform and names content relationships with The New England Journal of Medicine and the JAMA Network. Its current sitemap advertises a large official user-guide library covering Ask, evidence grades, guideline recommendations, drug information, clinical trials, complex cases, Deep Consult, patient handouts, continuing education, visit documentation, care teams, dialer calls, messages, and fax.

That breadth makes OpenEvidence more than a simple search box. It also means a buyer should identify the exact module being evaluated. Ask and evidence-grade features support information retrieval. Visits and dialer features concern documentation and communication. Homeo AI's comparison here is with evidence lookup and complex-question research, not with every product surface shown in the OpenEvidence guide.

The current official homepage still states that access is free for verified United States healthcare professionals. The public result does not establish a universal free plan, an India plan, or an enterprise price. During this review from India, the official routes returned HTTP 200 but displayed an unavailable state instead of the full product pages. That observed access behavior is a reason to verify eligibility directly, not proof of a permanent country policy.

OpenEvidence also publishes a current trust-center profile that names HIPAA, SOC 2 Type 2, and GDPR. Those are vendor-published compliance signals. A clinic considering identifiable information should request the underlying reports, scope, dates, exceptions, subprocessor details, and applicable agreement rather than treating badges as a complete security review.

Where OpenEvidence is genuinely strong

OpenEvidence has a clear advantage when the task is locating and synthesizing conventional medical information at the point of care. A practitioner can ask a focused question, inspect the cited evidence, compare recommendations, and follow the underlying source. The official guide's separate evidence-grade and complex-case routes indicate that the product is designed to expose more than one level of research depth.

Access without an individual subscription price is also a real strength for eligible users. It lowers the cost of running a controlled test. A verified United States clinician can compare answers with trusted guidelines, check whether citations support the exact statements made, and measure whether the tool reduces search time without committing to a paid personal plan.

OpenEvidence should be allowed to do its intended job in a fair comparison. It should not be penalized for lacking a homoeopathic repertory workflow it does not claim to provide. Its useful output is a researched answer with traceable conventional sources, not a rubric matrix or a homoeopathic remedy differential.

Evidence retrieval is not case analysis

A conventional evidence question usually asks what published research or guidelines say about a defined clinical issue. A homoeopathic case review asks how the patient's narrative, chronology, modalities, intensity, individual expressions, and practitioner observations should be structured and differentiated. The artifacts are different.

Homeo AI should be tested on whether original wording remains near each proposed interpretation, whether the practitioner can reject or revise symptom structure, whether candidate rubrics and source passages are inspectable, and whether the final differential can be reconstructed later. Its value is the correction path, not the fluency of its answer.

OpenEvidence can still be useful beside that workflow. A practitioner may need current conventional information to recognize a referral threshold, understand a diagnosis already made elsewhere, review medicine safety, or check a guideline. That research must remain separate from the homoeopathic repertorisation and must never be used to delay indicated conventional assessment or care.

Neither product earns trust merely by showing citations. A citation can be real yet fail to support the nearby sentence. A source can be relevant yet outdated or outside the patient's context. A rubric can exist yet be selected from an altered narrative. Every link and mapping needs a human review appropriate to the task.

Access, privacy, and procurement questions

OpenEvidence's public free-access statement is explicitly tied to verified United States healthcare professionals. Ask how credentials are checked, which professional roles qualify, whether students or international practitioners can register, which features are included, whether advertising or sponsored content appears, and whether any paid or organization plan changes the data and support terms. Do not infer those answers from a free label.

For an institutional evaluation, request the current privacy notice, terms, business associate agreement where applicable, data-processing agreement, subprocessor list, retention schedule, deletion procedure, model-improvement policy, audit-log options, and incident process. Confirm whether question text can contain protected health information, whether citations or generated answers are stored, how account administrators can access activity, and which controls differ by module.

Homeo AI needs the same product-specific review. Confirm current hosting, processing, support access, logs, retention, deletion, export, subprocessors, and incident handling. A narrower case workflow does not automatically make identifiable data appropriate.

A reproducible practitioner test

Prepare two matched sets using only completed, de-identified cases. Set A should contain twelve conventional information questions derived from past cases, such as locating a current guideline, checking whether a cited paper supports a statement, or identifying when the evidence is uncertain. Do not include names, exact dates, addresses, record numbers, images, or rare details. Keep an answer packet created from the cited primary guidance outside both tools.

For OpenEvidence, record access and verification steps, time to a usable answer, citation relevance, whether each source supports the exact claim, publication dates, guideline jurisdiction, missing counterevidence, uncertainty language, and correction effort. Test a straightforward question, an ambiguous question, a conflicting-guideline question, and a question where no firm answer should be given.

Set B should contain twelve completed homoeopathic narratives with known practitioner review notes. Include negation, chronology, modalities, code-switching, unusual patient wording, follow-ups, and two cases where a small qualifier changes the interpretation.

For Homeo AI, record whether original wording survives, which proposed symptoms and rubrics are accepted or rejected, whether source passages support accepted mappings, how the differential changes after correction, and whether another qualified practitioner can follow the reasoning at a later review.

Do not force both products to answer the same way. Score OpenEvidence on evidence fidelity, citation support, currency, uncertainty, access, and research time. Score Homeo AI on narrative fidelity, mapping transparency, source traceability, differential clarity, correction burden, and follow-up continuity. A fluent unsupported answer should fail. A detailed case analysis whose accepted rubric cannot be traced should also fail.

Use only completed, de-identified cases until the clinic approves the full data flow and legal basis. Neither tool replaces diagnosis, referral, emergency care, practitioner judgment, prescription, potency, dosage, or follow-up responsibility. Neither tool should make an emergency-care decision or decide whether a person needs urgent conventional assessment.

Conditional verdict

Choose OpenEvidence when the user qualifies for current access and the immediate task is conventional medical evidence retrieval with inspectable citations. Its focused medical corpus, official guide surfaces, and free verified-U.S.-HCP offer make it a strong research option for eligible clinicians.

Choose Homeo AI when the bottleneck is reviewing a homoeopathic consultation without losing the path from narrative to symptoms, rubrics, sources, differential, and follow-up. It should win only when that path is more visible and correctable in the clinic's test.

Use both when responsibilities are explicit. OpenEvidence can support a separate conventional evidence check, while Homeo AI supports a separately reviewed homoeopathic case workflow. Do not paste a generated evidence summary into a case record as if it were verified guidance, and do not present a homoeopathic differential as conventional evidence. The practitioner remains responsible for checking each source, each mapping, and the boundary between the two jobs.

Official sources checked

• OpenEvidence official product page
• OpenEvidence official evidence-grade guide
• OpenEvidence official complex-cases guide
• OpenEvidence official trust center

Product facts reviewed 2026-07-29. Confirm current features, prices, source libraries, and terms with the vendor.